Analysen zu Novartis AG
05.10.23 | Novartis Neutral | JP Morgan Chase & Co. | |
04.10.23 | Novartis Neutral | UBS AG | |
25.09.23 | Novartis Equal-weight | Morgan Stanley | |
31.08.23 | Novartis Neutral | JP Morgan Chase & Co. | |
19.07.23 | Novartis Neutral | JP Morgan Chase & Co. | |
18.07.23 | Novartis Neutral | UBS AG | |
18.07.23 | Novartis Neutral | JP Morgan Chase & Co. | |
15.06.23 | Novartis Neutral | UBS AG | |
05.06.23 | Novartis Neutral | UBS AG | |
19.05.23 | Novartis Neutral | JP Morgan Chase & Co. | |
18.05.23 | Novartis Neutral | UBS AG | |
26.04.23 | Novartis Neutral | JP Morgan Chase & Co. | |
12.04.23 | Novartis Neutral | JP Morgan Chase & Co. | |
28.03.23 | Novartis Neutral | UBS AG | |
28.03.23 | Novartis Hold | Deutsche Bank AG |
Aktuelle Aktienanalysen
11.02.25 | Fresenius Buy | UBS AG | |
11.02.25 | EssilorLuxottica Outperform | RBC Capital Markets | |
11.02.25 | Fresenius Medical Care Neutral | UBS AG | |
11.02.25 | Philips Neutral | UBS AG | |
11.02.25 | Siemens Healthineers Neutral | UBS AG | |
11.02.25 | Carl Zeiss Meditec Neutral | UBS AG | |
11.02.25 | Novo Nordisk Buy | Deutsche Bank AG | |
11.02.25 | L'Oréal Sell | Deutsche Bank AG | |
11.02.25 | UniCredit Buy | Jefferies & Company Inc. | |
11.02.25 | Klöckner Buy | Warburg Research | |
11.02.25 | BP Sector Perform | RBC Capital Markets | |
11.02.25 | CANCOM Buy | Hauck Aufhäuser Lampe Privatbank AG | |
11.02.25 | L'Oréal Underweight | JP Morgan Chase & Co. | |
11.02.25 | Kering Sector Perform | RBC Capital Markets | |
11.02.25 | Santander Kaufen | DZ BANK | |
11.02.25 | Kering Underweight | JP Morgan Chase & Co. | |
11.02.25 | FUCHS Buy | Deutsche Bank AG | |
11.02.25 | BP Buy | Jefferies & Company Inc. | |
11.02.25 | BP Underweight | JP Morgan Chase & Co. | |
11.02.25 | ams-OSRAM Neutral | JP Morgan Chase & Co. | |
11.02.25 | UBS Buy | Deutsche Bank AG | |
11.02.25 | Kering Neutral | UBS AG | |
11.02.25 | BP Buy | UBS AG | |
11.02.25 | Kering Hold | Jefferies & Company Inc. | |
11.02.25 | ams-OSRAM Buy | UBS AG | |
11.02.25 | TUI Neutral | UBS AG | |
11.02.25 | CANCOM Hold | Jefferies & Company Inc. | |
11.02.25 | UniCredit Overweight | JP Morgan Chase & Co. | |
11.02.25 | NORMA Group Buy | Warburg Research | |
11.02.25 | Amadeus Fire Buy | Warburg Research | |
11.02.25 | LEG Immobilien Buy | Warburg Research | |
11.02.25 | TUI Underweight | Barclays Capital | |
11.02.25 | RELX Outperform | Bernstein Research | |
11.02.25 | Ferrari Buy | UBS AG | |
11.02.25 | AstraZeneca Outperform | Bernstein Research | |
11.02.25 | ams-OSRAM Buy | Jefferies & Company Inc. | |
11.02.25 | NORMA Group Add | Baader Bank | |
11.02.25 | Adyen B.V. Parts Sociales Buy | UBS AG | |
11.02.25 | Glencore Outperform | RBC Capital Markets | |
11.02.25 | Ceconomy St. Add | Baader Bank | |
11.02.25 | McDonald's Buy | UBS AG | |
11.02.25 | Salesforce Neutral | UBS AG | |
11.02.25 | LVMH Moet Hennessy Louis Vuitton Neutral | UBS AG | |
11.02.25 | Kering Neutral | UBS AG | |
11.02.25 | EssilorLuxottica Neutral | UBS AG | |
11.02.25 | McDonald's Overweight | JP Morgan Chase & Co. | |
11.02.25 | Richemont Buy | UBS AG | |
11.02.25 | TUI Hold | Jefferies & Company Inc. | |
11.02.25 | TUI Market-Perform | Bernstein Research | |
11.02.25 | Prosus Overweight | JP Morgan Chase & Co. |